MILAN--(BUSINESS WIRE)--Sorin Group, (Reuters Code: SORN.MI) (MIL:SRN), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today that the first US implant of Solo Smart was performed by David Heimansohn, M.D. at St. Vincent’s Heart Hospital, Indianapolis (IN).
Solo Smart is the first and only valve with a removable stent to be approved in the US market. This unique bioprosthesis, made from bovine pericardium, has no synthetic material added, allowing it to mimic the healthy native aortic valve. Solo Smart maximizes blood flow and delivers excellent hemodynamic performance, while providing the ease of implantability of a stented valve.
Help employers find you! Check out all the jobs and post your resume.
